Inventor · disambiguated record
Soeren Oestergaard
Also filed as: OESTERGAARD SOEREN
6 granted patents·6 pending applications·45 citations·filing 2010–2024
80Inventor score
Top patents by PatentIndex Score
12 records- 0191US9067977B2Peptides derivatized with A-B-C-D- and their therapeutical useNOVO NORDISK AS·Filed 2013·Granted Jun 30, 2015·18 cites·22 claims
- 0286US9085637B2Selective PYY compounds and uses thereofNOVO NORDISK AS·Filed 2014·Granted Jul 21, 2015·12 cites·20 claims
- 0385US10246497B2Selective PYY compounds and uses thereofNOVO NORDISK AS·Filed 2014·Granted Apr 2, 2019·10 cites·12 claims
- 0477US10005824B2Selective PYY compounds and uses thereofNOVO NORDISK AS·Filed 2017·Granted Jun 26, 2018·4 cites·34 claims
- 0570US2024279299A1Co-agonists of the glp-1 and amylin receptorsNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0663US8859731B2Selective modification of proteinsKOFOD-HANSEN MIKAEL·Filed 2011·Granted Oct 14, 2014·1 cites·12 claims
- 0755US2014141001A1Anit-Human Interleukin-20 AntibodiesNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 0855US2014194599A1Anti-Human Interleukin-20 AntibodiesNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 0952US10583172B2HPYY(1-36) having a beta-homoarginine substitution at position 35NOVO NORDISK AS·Filed 2014·Granted Mar 10, 2020·0 cites·11 claims
- 1048US2022280611A1Solid composition comprising a pyy compound and a salt of n-(8-(2- hydroxybenzoyl)amino)caprylic acidNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 1145US2015141336A1Pancreatic Peptide Compounds and UseNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 1228US2013096055A1Long-acting y2 receptor agonistsKOFOED JACOB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soeren Oestergaard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →